HALO
Halozyme Therapeutics, Inc.Company with tickers: HALO
CIK
1159036
CUSIP
40637H109
Shares Outstanding
118,613,000
13F Activity (30d)
454 filings
422 filers
The company's filings as submitted to the SEC's EDGAR system — 10-K, 10-Q, 8-K, proxy statements and more — listed most recent first.
| Type | Filing Date | Period | Open |
|---|---|---|---|
| 8-K | 2020-01-14 | — | |
| 8-K | 2020-01-16 | — | |
| 8-K | 2020-02-24 | — | |
| 10-K | 2020-02-24 | 2019-12-31 | |
| 8-K | 2020-02-24 | 2020-02-18 | |
| 8-K | 2020-05-04 | 2020-04-30 | |
| 10-Q | 2020-05-11 | 2020-03-31 | |
| 8-K | 2020-05-11 | — | |
| 8-K | 2020-08-10 | — | |
| 10-Q | 2020-08-10 | 2020-06-30 | |
| 10-Q | 2020-11-02 | 2020-09-30 | |
| 8-K | 2020-11-02 | — | |
| 8-K | 2021-01-11 | — | |
| 8-K | 2021-01-13 | — | |
| 10-K | 2021-02-23 | 2020-12-31 | |
| 8-K | 2021-02-23 | — | |
| 8-K | 2021-02-25 | 2021-02-24 | |
| 8-K | 2021-03-01 | — | |
| 8-K | 2021-05-03 | 2021-05-01 | |
| 8-K | 2021-05-05 | — | |
| 8-K | 2021-05-07 | 2021-05-05 | |
| 8-K | 2021-05-10 | — | |
| 10-Q | 2021-05-10 | 2021-03-31 | |
| 10-Q | 2021-08-09 | 2021-06-30 | |
| 8-K | 2021-08-09 | — | |
| 8-K | 2021-11-02 | — | |
| 10-Q | 2021-11-02 | 2021-09-30 | |
| 8-K/A | 2021-11-02 | — | |
| 8-K | 2021-12-10 | 2021-12-08 | |
| 8-K | 2021-12-13 | — | |
| 8-K | 2021-12-29 | 2021-12-23 | |
| 8-K | 2022-01-10 | — | |
| 8-K | 2022-02-03 | 2022-02-02 | |
| 10-K | 2022-02-22 | 2021-12-31 | |
| 8-K | 2022-02-22 | — | |
| 8-K | 2022-03-15 | — | |
| 8-K | 2022-03-21 | 2022-03-16 | |
| 8-K | 2022-04-13 | 2022-04-12 | |
| 8-K | 2022-05-06 | 2022-05-05 | |
| 8-K | 2022-05-10 | — | |
| 10-Q | 2022-05-10 | 2022-03-31 | |
| 8-K | 2022-05-24 | — | |
| 8-K/A | 2022-08-09 | 2022-05-24 | |
| 10-Q | 2022-08-09 | 2022-06-30 | |
| 8-K | 2022-08-09 | — | |
| 8-K | 2022-08-15 | — | |
| 8-K | 2022-08-16 | 2022-08-15 | |
| 8-K | 2022-08-18 | 2022-08-15 | |
| 8-K | 2022-08-19 | 2022-08-18 | |
| 10-Q | 2022-11-08 | 2022-09-30 |
Showing 1–50 of 107 filings